Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-24

Clinical Trial Update: Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

An update on a mesenchymal stem cell trial for knee osteoarthritis spanning Phase 2 and Phase 3, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Osteoarthritis Knee | Phase 2, Phase 3 | Status: UNKNOWN